Tag: blood screening industry size

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Blood Screening Industry By 2029?

The dimension of the blood screening market has witnessed a robust expansion in the preceding years. The market value is set to escalate from $3.15 billion in 2024 to $3.44 billion in 2025, showcasing a compound annual growth rate (CAGR) of 9.4%. The historical growth trajectory is primarily due to the escalating demand for blood transfusion, the growing incidence of communicable diseases, prevailing government norms and standards, enhancement in blood donations and collections, as well as worldwide health apprehensions and pandemics.

The size of the blood screening market is predicted to significantly increase in the years to come, expanding to a worth of $5.33 billion in 2029 with a compound annual growth rate (CAGR) of 11.5%. Factors contributing to this predicted growth within the forecast period include developing healthcare infrastructure, public health education initiatives, progress in infectious disease detection techniques, and global health risks and readiness for pandemics. Looking forward, key trends in the period include a surge in infectious diseases, improved automation and efficiency, growing necessities for blood transfusions, an emphasis on the safety of these transfusions, and investigations into pathogen identification.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

Which Factors Are Steering Growth In The Blood Screening Market?

The rise in infectious diseases is anticipated to fuel the expansion of the blood screening market. Blood tests are routinely conducted to identify disease symptoms by searching for a specific antibody produced in response to the infectious agent, assisting healthcare providers in managing infectious diseases and hindering further infection transmission in patients and person-to-person disease spread. For example, the National Center for Biotechnology Information, a US government entity, reported in June 2022 that the incidence of infectious diseases in outpatient care has nearly tripled over two decades, rising from 8 to 26 per 1,000. As a result, the escalating prevalence of infectious diseases is contributing to the growth of the blood screening market.

Which Segment Accounts For The Largest Share In The Blood Screening Market?

The blood screeningmarket covered in this report is segmented –

1) By Product: Reagents And Kits; Instruments; Software And Services

2) By Technology: Nucleic Acid Testing; Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Tests; Western Blot Assays; Next-Generation Sequencing (NGS)

3) By End User: Blood Banks; Diagnostic Centers And Pathology Labs; Hospitals; Clinics; Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents; Testing Kits

2) By Instruments: Automated Analyzers; Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS); Data Analysis Software; Support And Consulting Services

Which Disruptive Trends Are Driving Change Across The Blood Screening Market?

Leading entities in the blood screening market are exploring technologies like liquid biopsy to advance the early detection of cancer, refine treatment tracking, and facilitate personalized medicine strategies. The liquid biopsy is a non-invasive examination that analyzes blood or other bodily fluids for the presence of cancer cells or tumor genetic material. For instance, in November 2023, Shield blood-based screening tests were launched by a US-based biotech firm, Guardant Health, Inc. This Shield test scrutinizes cell-free DNA (cfDNA) in blood circulation, which can suggest the existence of colorectal tumors or precancerous growths. It particularly searches for modifications in DNA fragments circulating in the blood due to the presence of cancer cells.

Who Are The Dominant Players In The Blood Screening Market Today?

Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

What Regional Factors Are Accelerating Growth In The Blood Screening Market?

North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9047&type=smp

Browse Through More Reports Similar to the Global Blood Screening Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Blood Screening Market Over The Five-Year Period 2025–2029?

The blood screening market size has shown robust growth in recent years. It is anticipated to expand from $3.15 billion in 2024 to $3.44 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.4%. This historical growth can be linked to heightened requirements for blood transfusions, an increasing prevalence of transmissible illnesses, existing government regulations and standards, a rise in blood donations and collection efforts, alongside global health concerns and pandemics.

The blood screening market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $5.33 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.5%. This projected growth during the forecast period is primarily driven by factors such as enhanced healthcare infrastructure, widespread public health awareness initiatives, breakthroughs in infectious disease diagnostics, escalating global health issues, and strategies for pandemic readiness. Key trends anticipated within this period encompass an increase in infectious diseases, greater emphasis on automation and operational efficiency, growing demands for blood transfusions, a heightened focus on transfusion safety, and continued research into pathogen detection methods.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

Which Drivers Are Shaping The Blood Screening Industry’s Market Share?

The rising occurrence of infectious diseases is anticipated to drive the expansion of the blood screening market in the future. Blood analysis frequently involves detecting specific antibodies produced in response to infectious agents, thereby assisting healthcare professionals in managing infectious diseases, limiting patient infection transmission, and curbing person-to-person spread. For example, data from June 2022 by the National Center for Biotechnology Information, a US-based government agency, shows that over two decades, the incidence of infectious diseases in outpatient settings nearly tripled, rising from 8 to 26 per 1,000. Consequently, the escalation in the prevalence of infectious diseases is fueling the development of the blood screening market.

How Is The Blood Screening Market Segmented?

The blood screeningmarket covered in this report is segmented –

1) By Product: Reagents And Kits; Instruments; Software And Services

2) By Technology: Nucleic Acid Testing; Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Tests; Western Blot Assays; Next-Generation Sequencing (NGS)

3) By End User: Blood Banks; Diagnostic Centers And Pathology Labs; Hospitals; Clinics; Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents; Testing Kits

2) By Instruments: Automated Analyzers; Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS); Data Analysis Software; Support And Consulting Services

Which Ongoing Trends Are Expected To Shape The Blood Screening Market Outlook?

Leading companies in the blood screening market are developing technologies such as liquid biopsy to advance early cancer detection, enhance treatment monitoring, and enable personalized medicine approaches. A liquid biopsy is a non-invasive procedure that examines blood or other bodily fluids to find cancer cells or genetic material derived from tumors. For example, in November 2023, Guardant Health, Inc., a US-based biotechnology firm, launched its Shield blood-based screening tests. The Shield test analyzes cell-free DNA (cfDNA) present in the bloodstream, which can indicate the presence of colorectal tumors or precancerous formations. It specifically identifies modifications in DNA fragments that are released into the blood from cancer cells.

Which Global Market Leaders Are Shaping The Future Of The Blood Screening Sector?

Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

What Are The Key Regional Factors Influencing The Blood Screening Market Growth?

North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Blood Screening Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9047&type=smp

Browse Through More Reports Similar to the Global Blood Screening Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Blood Screening Market?

The size of the blood screening market has seen significant expansion in the recent past. It is projected to increase from $3.15 billion in 2024 to $3.45 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.6%. The past growth can be explained by the increase in the need for blood transfusions, the surge in transmissible diseases, governmental rules and standards, a rise in blood donations and collections, and endemic health issues worldwide.

What Growth Rate Is Forecasted for the Blood Screening Market by 2029?

Anticipations are high for the blood screening market to experience robust expansion in the coming years, with the market projected to reach a value of $5.37 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 11.7%. Factors that would contribute to this development in the projected period include enhancement of healthcare facilities, public health education initiatives, progress in the methods of diagnosing contagious diseases, general health issues, and readiness for pandemics. Notable trends during the forecast period consist of an increase in infectious ailments, automation and efficiency improvements, elevated demands for blood transfusion, emphasis on transfusion safety, and investigations on pathogen detection.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

Which Key Companies Are Shaping the Future of the Blood Screening Market?

Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

Which Factors Are Driving Demand in the Blood Screening Industry?

The rise in the occurrence of infectious diseases is set to boost the advancement of the blood screening market. Blood tests are frequently performed to check for signs of sickness by identifying a particular antibody produced against the infecting organism, which assists doctors in treating infectious diseases and halting further infection spread in patients and the transmission of disease from person to person. For example, the National Center for Biotechnology Information, a government agency in the US, reported in June 2022 that over the past 20 years, the incidence of infectious diseases in outpatient care has almost tripled, from 8 to 26 per 1,000. Therefore, the surge in the occurrence of infectious diseases is propelling the growth of the blood screening market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9047&type=smp

How Is the Blood Screening Market Segmented by Several Divisions?

The blood screening market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software And Services

2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)

3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents, Testing Kits

2) By Instruments: Automated Analyzers, Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

What are the Emerging Market Trends Driving the Growth of the Blood Screening Industry?

Key stakeholders in the blood screening market, such as Guardant Health, Inc., are advancing technologies like liquid biopsy. This development stands to improve early cancer detection, streamline treatment monitoring, and facilitate personalized medical treatments. Liquid biopsy serves as a less aggressive testing method that examines blood and other bodily fluids to identify cancer cells or tumor DNA. For example, in November 2023, the American biotech company Guardant Health, Inc. introduced Shield, a blood-based screening test. This particular test investigates cell-free DNA (cfDNA) circulating in the blood, signaling the potential existence of colorectal tumors or precancerous formations. It particularly targets changes in DNA fragments that cancer cells release into the bloodstream.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Which Regions Are Driving Growth in the Blood Screening Market?

North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9047

This Report Delivers Insight On:

1. How big is the blood screening market, and how is it changing globally?

2. Who are the major companies in the blood screening market, and how are they performing?

3. What are the key opportunities and risks in the blood screening market right now?

4. Which products or customer segments are growing the most in the blood screening market?

5. What factors are helping or slowing down the growth of the blood screening market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Blood Screening Market?

The size of the blood screening market has seen significant expansion in the recent past. It is projected to increase from $3.15 billion in 2024 to $3.45 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.6%. The past growth can be explained by the increase in the need for blood transfusions, the surge in transmissible diseases, governmental rules and standards, a rise in blood donations and collections, and endemic health issues worldwide.

What Growth Rate Is Forecasted for the Blood Screening Market by 2029?

Anticipations are high for the blood screening market to experience robust expansion in the coming years, with the market projected to reach a value of $5.37 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 11.7%. Factors that would contribute to this development in the projected period include enhancement of healthcare facilities, public health education initiatives, progress in the methods of diagnosing contagious diseases, general health issues, and readiness for pandemics. Notable trends during the forecast period consist of an increase in infectious ailments, automation and efficiency improvements, elevated demands for blood transfusion, emphasis on transfusion safety, and investigations on pathogen detection.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

Which Key Companies Are Shaping the Future of the Blood Screening Market?

Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

Which Factors Are Driving Demand in the Blood Screening Industry?

The rise in the occurrence of infectious diseases is set to boost the advancement of the blood screening market. Blood tests are frequently performed to check for signs of sickness by identifying a particular antibody produced against the infecting organism, which assists doctors in treating infectious diseases and halting further infection spread in patients and the transmission of disease from person to person. For example, the National Center for Biotechnology Information, a government agency in the US, reported in June 2022 that over the past 20 years, the incidence of infectious diseases in outpatient care has almost tripled, from 8 to 26 per 1,000. Therefore, the surge in the occurrence of infectious diseases is propelling the growth of the blood screening market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9047&type=smp

How Is the Blood Screening Market Segmented by Several Divisions?

The blood screening market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software And Services

2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)

3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents, Testing Kits

2) By Instruments: Automated Analyzers, Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

What are the Emerging Market Trends Driving the Growth of the Blood Screening Industry?

Key stakeholders in the blood screening market, such as Guardant Health, Inc., are advancing technologies like liquid biopsy. This development stands to improve early cancer detection, streamline treatment monitoring, and facilitate personalized medical treatments. Liquid biopsy serves as a less aggressive testing method that examines blood and other bodily fluids to identify cancer cells or tumor DNA. For example, in November 2023, the American biotech company Guardant Health, Inc. introduced Shield, a blood-based screening test. This particular test investigates cell-free DNA (cfDNA) circulating in the blood, signaling the potential existence of colorectal tumors or precancerous formations. It particularly targets changes in DNA fragments that cancer cells release into the bloodstream.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Which Regions Are Driving Growth in the Blood Screening Market?

North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9047

This Report Delivers Insight On:

1. How big is the blood screening market, and how is it changing globally?

2. Who are the major companies in the blood screening market, and how are they performing?

3. What are the key opportunities and risks in the blood screening market right now?

4. Which products or customer segments are growing the most in the blood screening market?

5. What factors are helping or slowing down the growth of the blood screening market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the blood screening industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Blood Screening Market From 2025 To 2029?

The size of the blood screening market has seen robust growth in the past few years. It is projected to increase from a value of $3.15 billion in 2024 to $3.45 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. This growth in the historical period is due to factors such as a rise in the requirements for blood transfusion, an increasing occurrence of communicable diseases, government rules and standards, an increment in blood donations and collections, and worldwide health concerns and epidemics.

The impending years are likely to witness a swift expansion in the blood screening market size, with an anticipated steeping to $5.37 billion in 2029, at a compound annual growth rate (CAGR) of 11.7%. The surging growth during the stipulated period can be justified due to numerous factors including the evolution of healthcare infrastructure, public health enlightenment agenda, innovative progress in infectious disease detection, factors of global health, and readiness for pandemics. The major trend-setters during this phase could be an increase in infectious diseases, enhancements in automation and operational efficiency, escalating needs for blood transfusions, emphasis on the safety of these transfusions, and investigations in the realm of pathogen detection.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

What are the Fundamental Drivers and Innovations Shaping the Blood Screening Market?

The surge in infectious diseases prevalence is anticipated to fuel the blood screening market’s expansion in the future. Blood analysis is frequently used to detect illness symptoms by identifying a specific antibody produced against the infectious organism. This primary information significantly aids physicians in effectively treating infectious diseases and preventing further spread of infection from patient to patient. For example, the National Center for Biotechnology Information, a United States government agency, reported in June 2022 that the prevalence of infectious diseases in outpatient care had nearly tripled over two decades, rising from 8 to 26 per 1,000. Consequently, the rising incidence of infectious diseases is propelling the growth of the blood screening market.

How Is the Blood Screening Market Segmented?

The blood screening market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software And Services

2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)

3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents, Testing Kits

2) By Instruments: Automated Analyzers, Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9047&type=smp

Which Regions Are Driving the Next Phase of the Blood Screening Market Growth?

North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Blood Screening Market?

Key players in the blood screening industry are innovating with technologies like liquid biopsy to advance early cancer detection, optimize treatment tracking, and facilitate individualized treatment strategies. Liquid biopsy refers to a simple, non-invasive test that examines blood or other body fluids for signs of cancer cells or signs of genetic changes in tumors. For example, in November 2023, Guardant Health, Inc., a reputable biotechnology firm based in the United States, unveiled their Shield blood-based screening examinations. These tests study the cell-free DNA (cfDNA) circulating in the blood, which can signal the presence of colorectal tumors or pre-cancerous growths. They specifically target changes in DNA fragments that cancer cells emit into the blood.

View the full report here:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

How Is the Blood Screening Market Defined and What Are Its Core Parameters?

Blood screening refers to a method of screening blood, plasma, or blood components for transfusion or use in blood products. It is used to screen for antibodies or tumor markers, to seek for disease-causing substances or symptoms, or to evaluate treatment effectiveness.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9047

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Blood Screening Market?

The escalating occurrence of infectious diseases is predicted to drive the growth of the blood screening market in the future. Blood is frequently examined for signs of disease by searching for a unique antibody produced against the infectious pathogen. This assists medical professionals in managing infectious diseases and halting further transmission of infection among patients and person-to-person contamination. For example, the National Center for Biotechnology Information, a government agency based in the US, reported in June 2022 that the occurrence of infectious diseases in outpatient care has nearly tripled in the last two decades, going up from 8 to 26 per 1,000. Consequently, the surge in the occurrence of infectious diseases is fueling the expansion of the blood screening market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

#What is the Growth Potential of the Blood Screening Market, and How Will It Perform by 2034?

Over the past few years, the size of the blood screening market has seen a robust growth. It is expected that this market will expand from $3.15 billion in 2024 to $3.45 billion in 2025, with a compound annual growth rate (CAGR) of 9.6%. The exponential growth during the historic period is credited to factors like a surge in the necessity for blood transfusions, escalated occurrence of communicable diseases, government norms and standards, an upswing in blood donations and collection, and global health concerns, including pandemics.

Anticipated to witness a significant surge in the forthcoming years, the blood screening market is projected to escalate to $5.37 billion by 2029, advancing at a composite annual growth rate (CAGR) of 11.7%. The projected growth during the forecast period is speculated to be driven by enhancements in healthcare infrastructure, public health enlightenment initiatives, progress in the diagnostics of infectious diseases, global health apprehensions, and readiness for pandemics. The forecast period will experience substantial trends such as increase in infectious diseases, enhanced automation and efficiency, proliferating demands for blood transfusions, emphasis on ensuring safety in transfusions, and ongoing research in pathogen detection.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9047

What New Market Trends Are Reshaping theBlood Screening Market and Its Opportunities?

Leading businesses within the blood screening market are introducing advancements like liquid biopsy to better early cancer identification, enhance the monitoring of treatments, and facilitate personalized treatment methods. Liquid biopsy refers to a minimally invasive examination that scrutinizes blood or other body fluids to discover cancer cells or genetic material from tumors. To illustrate, in November 2023, Guardant Health, Inc., a biotech firm based in the US, rolled out the Shield blood-based screening tests. These tests examine cell-free DNA (cfDNA) present in the bloodstream, a potential marker of colorectal tumors or precancerous formations. They specifically search for changes in DNA fragments, which can be shed into the blood by cancer cells.

Who Are the Leading Market Players Fueling Growth in the Blood Screening Market Trend?

Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

How is the Global Blood Screening Market Segemented?

The blood screening market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software And Services

2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)

3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents, Testing Kits

2) By Instruments: Automated Analyzers, Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9047&type=smpGlobal Blood Screening Market, Global Blood Screening Market Report, Global Blood Screening Market Trends, Global Blood Screening Market Size

Browse Through More Reports Similar to the Gobal Blood Screening Maret 2025, By The Business Research Company:

Analytical Laboratory Instrument Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/analytical-laboratory-instrument-global-market-report

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Blood Group Typing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the blood screening market grown in recent years?

The market capacity of blood screening has seen significant growth over recent times. Anticipated to grow from a size of $3.15 billion in 2024 to $3.45 billion in 2025, it boasts a compound annual growth rate (CAGR) of 9.6%. The growth experienced during the historic period is attributable to factors including the heightened need for blood transfusions, surge in transmissible diseases, government norms and standards, rise in blood donations and collections, and global health crises and pandemics.

How is the blood screening market size expected to evolve during the forecast period?

The market size of blood screening is anticipated to experience swift growth in the upcoming years, reaching a value of $5.37 billion in 2029 with a compound annual growth rate (CAGR) of 11.7%. This projected growth during the forecast period can be ascribed to factors such as advancements in healthcare infrastructures, public health consciousness initiatives, progress in diagnosing infectious diseases, concerns about global health, and readiness for potential pandemics. The forecast period is expected to witness key trends such as an increase in infectious diseases, efficiency and automation, an upsurge in the demand for blood transfusion, a concentration on the safety of transfusion, and a surge in research for pathogen detection.

Get your blood screening market report here!

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Which key drivers are propelling the blood screening market’s growth?

The escalation in the incidence of contagious diseases is predicted to boost the expansion of the blood screening market in the future. Blood examination is typically done to detect signs of ailments by identifying a particular antibody produced against the pathogenic carrier. This assists healthcare professionals in managing infectious diseases and stopping further spread of infections among patients and direct transmissions. For example, in June 2022, as per the data from the National Center for Biotechnology Information, a government agency in the United States, there has been almost a threefold rise in the incidence of infectious diseases in outpatient healthcare over twenty years, going up from 8 to 26 per 1,000. As a result, the escalation in contagious disease incidence is propelling the rise of the blood screening market.

What are the market segments in the blood screening industry?

The blood screening market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software And Services

2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)

3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents, Testing Kits

2) By Instruments: Automated Analyzers, Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

Which leading companies are shaping the growth of the blood screening market?

Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton Dickinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

What key trends are currently impacting the blood screening market’s development?

Leading entities within the blood screening market are introducing innovation like liquid biopsy, aiming to improve early identification of cancer, refine treatment monitoring, and facilitate personalized medical protocols. Liquid biopsy is a less intrusive procedure that enables examination of blood or body fluids to trace cancer cells or tumor-related genetic material. For example, in November 2023, Shield blood-based screening tests were introduced by Guardant Health, Inc., a biotech company based in the US. This Shield test examines cell-free DNA (cfDNA) circulating in the bloodstream, which may signal the existence of colorectal tumors or precancerous developments—it specifically identifies changes in DNA fragments that have been released into the blood by cancer cells.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9047

Which geographic areas are influencing the growth of the blood screening market?

North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Analytical Laboratory Instrument Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/analytical-laboratory-instrument-global-market-report

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Blood Group Typing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the Blood Screening Market’s CAGR Through 2034?

The market size of blood screening has seen a robust growth in the past few years. The market size which was $3.15 billion in 2024 is projected to rise to $3.45 billion in 2025, experiencing a compound annual growth rate (CAGR) of 9.6%. The growth historically can be correlated to factors such as an increase in the need for blood transfusions, a rise in communicable diseases, governmental regulations and standards, a surge in blood donations and collections, as well as global health crises and pandemics.

Expectations are high for significant expansion in the blood screening market over the next several years. This market is projected to reach $5.37 billion by 2029, with a compound annual growth rate (CAGR) of 11.7%. Its development in the forecasted period is connected to increased public health awareness, enhanced healthcare infrastructure, breakthroughs in infectious disease diagnosis, global health issues, and readiness for potential pandemics. Notable upcoming trends include a surge in infectious diseases, automation and improvements in efficiency, increased demand for blood transfusion, emphasis on transfusion safety, and research into pathogen detection.

What Key Drivers Are Accelerating the Growth of the blood screening Market During the Forecast Period?

The escalating occurrence of infectious diseases is set to boost the expansion of the blood screening market. Frequently, blood is examined to detect signs of disease by identifying a particular antibody produced against the infecting body. This assists medical professionals in managing infectious diseases and halting increased infection dissemination among patients and from one individual to another. For example, as per the US government agency National Center for Biotechnology Information, in June 2022, the infectious disease incidence in outpatient care has nearly tripled in the past two decades, rising from 8 to 26 per 1,000. Consequently, the upsurge in infectious diseases prevalence is fueling the blood screening market’s growth.

Request Your Free Blood Screening Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

What Are the Leading Industry Players Dominating the Blood Screening Market?

Major companies operating in the blood screening market include:

• Abbott Laboratories_x000D_

• Grifols S.A._x000D_

• Becton Dickinson and Company_x000D_

• F. Hoffmann-La Roche AG_x000D_

• bioMérieux S.A._x000D_

What Are the Latest Trends Leading to Disruption in the Blood Screening Market?

Prominent businesses within the blood screening market are innovating new technologies like liquid biopsy, in an effort to advance early cancer detection, make treatment monitoring more effective, and facilitate personalized medicine methodologies. A liquid biopsy is a test with minimal invasion which scrutinizes blood or different body fluids in order to identify cancer cells or genetic bodies associated with tumors. As an example, in November of 2023, Guardant Health Inc., a biotechnology firm from the United States, introduced Shield, a blood-based screening test. The Shield test focuses on examining cell-free DNA (cfDNA) within the bloodstream that may signify the existence of colorectal tumors or potentially cancerous growths. It specifically targets alterations in DNA fragments, which are discharged into the bloodstream from cancer cells.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Which Industry Segments Are Leading the Development and Expansion of the Blood Screening Market?

The blood screening market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software And Services

2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)

3) By End User: Blood Banks, Diagnostic Centers And Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Reagents And Kits: Diagnostic Reagents, Testing Kits

2) By Instruments: Automated Analyzers, Manual Testing Equipment

3) By Software And Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Support And Consulting Services

Which Regions Are Significant to the Growth of the Blood Screening Market?

North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Core Features That Define the Blood Screening Market?

Blood screening refers to a method of screening blood, plasma, or blood components for transfusion or use in blood products. It is used to screen for antibodies or tumor markers, to seek for disease-causing substances or symptoms, or to evaluate treatment effectiveness.

Browse Through More Similar Reports By The Business Research Company:

Analytical Laboratory Instrument Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/analytical-laboratory-instrument-global-market-report

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Blood Group Typing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: